Trials / Completed
CompletedNCT00604539
Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee
Study of the Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Bioiberica · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of a chondroitin sulphate conventional treatment on the degree of severity of synovitis, as measured by magnetic resonance in patients with knee OA with clinical synovitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chondroitin sulphate (Condrosan) | 800 mg (two capsules of 400 mg each) taken once a day for one year |
| DRUG | Placebo | Two placebo capsules taken once a day for six months followed by an additional six month treatment of 800 mg (two capsules of 400 mg of Chondroitin sulphate each) taken once a day |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-11-01
- First posted
- 2008-01-30
- Last updated
- 2011-12-19
Locations
4 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00604539. Inclusion in this directory is not an endorsement.